Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Pressemeddelelse

Redeye: Acconeer - Making 2026 Sense-ational

Acconeer

Acconeer's first quarter 2025 net sales growth of 20% y/y (or -12% adjusted for the postponed order) was weaker than anticipated. This, coupled with slightly higher OPEX, resulted in an EBITDA miss. However, results remain volatile as they are contingent on specific order shipments. Despite the miss, the share price held firm, owing to the strong cash position secured via the rights issue announced with the fourth-quarter report. The reorganisation has bolstered customer confidence, leading to market share gains and larger orders from an increased number of customers. Redeye believes the key catalysts will be larger orders within the product areas and an A2 design win, which would support investor confidence in the reiterated >SEK300m 2027 target. Redeye revised its estimates and fair value range accordingly.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


Acconeer - Making 2026 Sense-ational

Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.